Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Indivior Pharmaceuticals, Inc. (INDV) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $4.58B, a trailing price-to-earnings ratio of 10.6 and a free-cash-flow yield of -1.9%. Over the most recent reported fiscal year, revenue grew 4.3% and free cash flow per share fell 2042.5%.